42 results
F-1
EX-10.6
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
responsibility for prosecuting and maintaining any of such applications Company shall have the right to do so at its own cost.
For the avoidance of doubt … , this letter refers only to the transfer of responsibility for the prosecution of the above-identified applications. Ownership of the applications
DRS/A
EX-10.6
CNTB
Connect Biopharma Holdings Ltd
26 Jan 21
Draft registration statement (amended)
12:00am
responsibility for prosecuting and maintaining any of such applications Company shall have the right to do so at its own cost.
For the avoidance of doubt … , this letter refers only to the transfer of responsibility for the prosecution of the above-identified applications. Ownership of the applications
F-1/A
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
to the Company’s operations. These include, without limitation, laws covering the marketing of products, bribery and kickbacks.
It is the responsibility … responsibility to ensure that all of our financial disclosures are full, fair, accurate, timely and understandable. These employees must understand
6-K
CNTB
Connect Biopharma Holdings Ltd
1 Mar 22
Current report (foreign)
4:16pm
roles of increasing responsibility at Eli Lilly & Company from January 2010 to January 2018, serving most recently as Global Senior Medical Director
F-1
EX-10.10
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
responsibility for the repair of the house shall be limited to the original structure of the house, and the power supply lines and public parts that have … control that cause the instability or interruption of services such as water, electricity, network, etc., Party A need not assume any responsibility
DRS
EX-10.7
pfny iqfpnu08dd1
17 Dec 20
Draft registration statement
12:00am
20-F
EX-4.12
tqq1kx
31 Mar 22
Annual report (foreign)
4:33pm
DRS
EX-10.6
gri4dpih kmp4
17 Dec 20
Draft registration statement
12:00am
F-1
EX-99.2
ip5dc2f7oborsme2dbii
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.9
gcn0r 22w9x
26 Feb 21
Registration statement (foreign)
4:56pm
F-1/A
EX-99.2
syepfo 41t
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.2
2y5kfe82jo0pns48qb7
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1MEF
EX-8.2
wb9i0bv 6tu
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
6-K
EX-99.1
4bc5m
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
6-K
EX-99.1
od3rev
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
ix2govbw
23 Jun 23
House Lease Contract
4:31pm
F-1
EX-10.14
d8jee
26 Feb 21
Registration statement (foreign)
4:56pm
20-F
EX-4.10
mk5quj
31 Mar 22
Annual report (foreign)
4:33pm
F-1
EX-10.15
223xd x04
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.12
r2u8sk2g wy3wbdtz
26 Feb 21
Registration statement (foreign)
4:56pm